CD8A and melanoma: identified PD‐1 expression on CD8+ TILs as a reliable indicator of clonally expanded, tumor‐reactive T cells in melanoma.[83] Further insights into tumor‐reactive T cell phenotypes have emerged from studies of mutation‐associated neoantigen (MANA)‐specific T cells.